CTSA INFRASTRUCTURE FOR AIDS RESEARCH

CTSA 艾滋病研究基础设施

• 批准号: 8365211
• 负责人: DAVID M. CENTER
• 金额: $ 21.06万
• 依托单位: BOSTON UNIVERSITY MEDICAL CAMPUS
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-05-01 至 2012-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8365211
• 关键词: Acquired Immunodeficiency Syndrome; Award; Boston; Clinical Sciences; Clinical and Translational Science Awards; Research; Research Infrastructure; Translational Research; Universities; programs

This subproject represents an estimate of the percentage of the CTSA funding that is being utilized for a broad area of research (AIDS research, pediatric research, or clinical trials). The Total Cost listed is only an estimate of the amount of CTSA infrastructure going towards this area of research, not direct funding provided by the NCRR grant to the subproject or subproject staff. Boston University proposes to create a Clinical and Translational Science Institute, the BU-BRIDGE Institute, that will integrate, connect and expand our current research and university programs and, thereby, provide an academic and intellectual home for the next generation of clinical and translational investigators. The Institute will be organized around five Divisions: 1} Translational Science Incubator; 2) Informatics; 3) Clinical Research Enhancements; 4) Community Engagements; and 5) Research Education and Training. These five divisions are specifically designed to support the bi-directional development and translation of ideas that begin in the laboratory or bedside move seamlessly back and forth to result in new relevant tools to improve health, health care and delivery. The BU-BRIDGE will accomplish five specific aims: 1) Coordinate existing and identify new collaborations among existing BU scientists with the potential to develop into multidisciplinary translational programs, and facilitate the BU "one stop shopping" program for creating intellectual property and commercialization of translational scientific ideas; 2) Support the further development of existing and the creation of new translational programs and cores through a network of pilot grants. 3) Provide new and existing Clinical and Translational research programs with an expanded and enriched menu of BU-BRIDGE-based institutional support, including an improved, user friendly medical informatics syslem (warehouse), expansion of research from our GCRC into community populations, provide an integrated approach to ethics, regulatory issues, study design, analysis and implementation of health interventions 4) Provide the conduit for bi- directional flow of ideas between clinicians and clinical and basic scientists to more fully engage the community in the research process including setting priorities for investigation, designing studies, ensuring ethical research conduct and implementing best practices based on study results; 5) Serve as the Center for training the next generation of investigators with the proper tools to translate basic science into clinical research. The new institute is cross University entity that supercedes traditional departments and schools. It encorporates multiple key university programs including the National Emerging Infectious Diseases Laboratory, Framingham Heart Study, Boston University Office of Technology Development Commercialization portfolio, Departments of Biomedical Engineering and Bioinformatics, Sargent College of Allied Heath Professionals, the Boston Health Net, Boston Medical Center and VA Hospitals that support the university wide commitment for a home for translational research. The CTSA award will provide the resources to transform the institute by leveraging existing strengths to create an environment that will link new ideas, faculty, trainees and university programs to speed innovations in medical science. The mission of the BU-BRIDGE is relevant to the public health as it will enhance the development of healthcare practices available to members of the local and national communities.

该子项目代表CTSA资金百分比的估计值 被用于广泛的研究领域（艾滋病研究，儿科研究或 临床试验）。 列出的总成本只是CTSA数量的估计值 基础设施朝向这一研究领域，而不是直接提供的资金 NCRR授予subproject或subproject人员。 波士顿大学建议建立一个临床和转化科学学院Bu-Bridge Institute，该研究所将整合，联系和扩展我们当前的研究和大学课程，从而为下一代临床和翻译研究人员提供学术和知识分子。该研究所将围绕五个部门组织：1}转化科学孵化器； 2）信息学； 3）临床研究增强； 4）社区订婚； 5）研究教育和培训。这五个部门是专门设计的，旨在支持在实验室或床头层中无缝移动的思想的双向发展和翻译，从而为改善健康，医疗保健和交付的新工具提供了新的相关工具。 Bu-Bridge将实现五个具体目标：1）协调现有的现有BU科学家之间的新合作，并有可能发展为多学科的翻译计划，并促进BU“一站购物”计划，以创建知识产权和翻译科学思想的商业化； 2）支持通过试点赠款网络的现有转化计划和核心的进一步发展。 3）提供新的和现有的临床和翻译研究计划，并提供基于Bu桥的机构支持的扩展和丰富菜单，包括改进的，用户友好的医学信息学系统（仓库），我们的GCRC将研究扩展到社区人群中，为综合的伦理学和临床授权提供了临床，研究设计，研究和实施的临床，分析，分析和实施 - 科学家将社区更充分地参与研究过程，包括设定调查的优先级，设计研究，确保道德研究行为和基于研究结果实施最佳实践； 5）作为培训下一代研究人员的中心，并使用适当的工具将基础科学转化为临床研究。新研究所是跨大学实体，它推翻了传统部门和学校。它结合了多个关键的大学计划，包括国家新兴疾病实验室，弗雷明汉心脏研究，波士顿大学技术开发办公室商业化投资组合，生物医学工程和生物信息学系，萨金特·霍斯·希思·希思专业人士学院，波士顿健康网络，波士顿医疗中心和VA医院的波士顿健康网络和VA医院，以支持大学大型研究。 CTSA奖将通过利用现有优势创造一个将新想法，教职员工，学员和大学计划来加快医学科学创新的环境来提供改造研究所的资源。 Bu-Bridge的使命与公共卫生有关，因为它将增强当地和国家社区成员可用的医疗保健实践的发展。